세계의 세포 치료 처리 시장 : 각종 기술

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

The North American market for cell therapy processing is estimated to grow from $1.2 billion in 2025 to reach $3.3 billion by 2030, at a CAGR 22.2% from 2025 to 2030.

The Asia-Pacific market for cell therapy processing is estimated to grow from $568.7 million in 2025 to reach $1.8 billion by 2030, at a CAGR 25.5% from 2025 to 2030.

Report Scope

The report provides an overview of global cell therapy processing and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025 with forecasts through 2030. The market is segmented based on offering type, application and regions. By offering, the market is segmented into products, software and services. By application, the market is segmented into cancer, musculoskeletal disorders, neurological disorders, cardiovascular diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Report Includes

• 32 data tables and 58 additional tables
• An overview of the global market and technologies for cell therapy processing
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to the cell therapy processing, accompanied by a market share analysis by offerings, application and region
• Analysis of current and future demand in the global cell therapy processing market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
• Market share analysis of the key market participants in the cell therapy processing market, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Profiles of the major companies, including Thermo Fisher Scientific Inc., Danaher Corp., Lonza, Miltenyi Biotech and Sartorius AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Market Insights
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Cell Therapy Manufacturing Process
• Cell Therapy Supply Chain
• Macroeconomic Factors Analysis
• Demographic Factors
• Geopolitical Factors
• Impact of U.S. Tariffs
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Growing Demand for Regenerative Medicine
• Increasing Investments in Cell and Gene Therapy (CGT) Research
• Expanding Clinical and Commercial Activities
• Growing Number of Strategic Initiatives
• Rising Aging Population and the Increasing Prevalence of Chronic Diseases
• Market Restraints
• Complex Manufacturing and Supply Chain
• High Cost of Development
• Lack of Skilled Workforce
• Regulatory Hurdles
• Market Opportunities
• Decentralized Manufacturing
• Shift Toward Allogeneic Therapies

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Scenario by Country/Region
• U.S. FDA
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• Automation
• First-Generation Automated Platforms
• Second-Generation Automated Platforms
• Single-Use Technologies and Miniaturization

Chapter 6 Market Segment Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Type of Offerings
• Key Takeaways
• Products
• Services
• Software
• Market Analysis by Application
• Key Takeaways
• Cancer
• Musculoskeletal Disorders (Bone and Skeletal Muscle Repair)
• Neurological Disorders
• Cardiovascular Disorders
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Agreements, Collaborations and Partnerships
• Acquisitions
• Investments and Expansions

Chapter 8 Sustainability in Cell Therapy Processing Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the Cell Therapy Processing Industry
• Environmental Factors
• Social Factors
• Governance Factors
• ESG Sustainability Trends and Initiatives
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks

Chapter 9 Appendix

• Research Methodology
• Information Sources
• Abbreviations
• Company Profiles
• BIO-TECHNE
• BIOSPHERIX LLC.
• CYTIVA
• FRESENIUS KABI AG
• FUJIFILM BIOSCIENCES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• REVVITY
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• TERUMO CORP.
• THERMO FISHER SCIENTIFIC INC.
• THERMOGENESIS
• Emerging Start-ups/Market Disruptors